共 50 条
Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study
被引:14
|作者:
Jastaniah, Wasil
[1
,2
]
Al Ghemlas, Ibrahim
[3
,4
]
Al Daama, Saad
[5
]
Ballourah, Walid
[6
]
Bayoumy, Mohammad
[7
]
Al-Anzi, Faisal
[8
]
Al Shareef, Omar
[9
]
Alsultan, Abdulrahman
[10
]
Abrar, Mohammed Burhan
[2
]
Al Sudairy, Reem
[11
]
机构:
[1] Umm AlQura Univ, Fac Med, Dept Pediat, Mecca, Saudi Arabia
[2] King Abdul Aziz Med City, Princess Noorah Oncol Ctr, Jeddah, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[4] Alfaisal Univ, Fac Med, Riyadh, Saudi Arabia
[5] King Fahad Specialist Hosp, Dammam, Saudi Arabia
[6] King Fahad Med City, Riyadh, Saudi Arabia
[7] King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia
[8] Prince Faisal Bin Bandar Canc Ctr, Qaseem, Saudi Arabia
[9] Prince Sultan Mil Med City, Riyadh, Saudi Arabia
[10] King Saud Univ, Coll Med, Dept Pediat, Riyadh, Saudi Arabia
[11] King Abdul Aziz Med City, King Abdullah Specialized Childrens Hosp, Dept Pediat Hematol Oncol, Riyadh, Saudi Arabia
来源:
关键词:
AML;
Acute leukemia;
Ethnic;
Response;
Risk;
Developing;
CHILDRENS-ONCOLOGY-GROUP;
BONE-MARROW-TRANSPLANTATION;
STEM-CELL TRANSPLANTATION;
PEDIATRIC AML;
CURRENT CONTROVERSIES;
SUPPORTIVE CARE;
CANCER-GROUP;
TRIAL;
RISK;
ADOLESCENTS;
D O I:
10.1016/j.leukres.2016.08.009
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Geographic variation and ethnicity have been implicated to influence the outcome of pediatric acute myeloid leukemia (AML). Furthermore, survival outcomes from developing countries are reported to be inferior to developed nations. We hypothesized that risk-and response-based outcome in high-income resource-rich developing countries would be comparable to developed nations as access to care and supportive measures would be similar. A total of 193 children diagnosed with de novo AML between January 2005 and December 2012 were identified, of those 175 were evaluable for outcome. Patients were stratified into low-risk (LR), intermediate-risk (IR), or high-risk (HR) groups. The complete remission (CR), early death, and induction failure rates were: 85.7%, 2.3%, and 12%; respectively. The 5-year cumulative incidences of relapse (CIR) and non-relapse mortality (NRM) were 43.1% and 9.8% respectively; overall survival (OS) was 58.8 +/- 4% and event-free survival (EFS) 40.9 +/- 4.1%. The 5-year OS for LR, IR, and HR groups were 72.0 +/- 6.9%, 59.8 +/- 6.2%, and 45.1 +/- 7.4%; respectively (p = 0.003); and EFS 50.5 +/- 8.0%, 46.3 +/- 6.4%, and 23.3 +/- 6.4%; respectively (p = 0.001). This study demonstrated comparable outcomes to those reported from developed countries. This suggests that utilization of risk-and response based protocols in developing countries can overcome ethnic and geographic variation, if access to care and supportive measures were similar. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文